BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16549257)

  • 1. Population screening for single genes that codetermine common diseases in adulthood had limited effects.
    Lamberts SW; Langeveld CH; Vandenbroucke JP
    J Clin Epidemiol; 2006 Apr; 59(4):358-64. PubMed ID: 16549257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic testing in clinical practice.
    Lamberts SW; Uitterlinden AG
    Annu Rev Med; 2009; 60():431-42. PubMed ID: 18947300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics and preventive health care.
    Emery J; Barlow-Stewart K; Metcalfe SA; Sullivan D
    Aust Fam Physician; 2007 Oct; 36(10):808-11. PubMed ID: 17925900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening.
    Leren TP; Finborud TH; Manshaus TE; Ose L; Berge KE
    Community Genet; 2008; 11(1):26-35. PubMed ID: 18196915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia.
    Civeira F; Ros E; Jarauta E; Plana N; Zambon D; Puzo J; Martinez de Esteban JP; Ferrando J; Zabala S; Almagro F; Gimeno JA; Masana L; Pocovi M
    Am J Cardiol; 2008 Nov; 102(9):1187-93, 1193.e1. PubMed ID: 18940289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nephrotic syndrome as a first manifestation of familial Mediterranean fever].
    Gingold-Belfer R; Bergman M; Ori Y; Salman H
    Harefuah; 2006 Oct; 145(10):706-8, 784. PubMed ID: 17111701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population screening for genetic disorders in the 21st century: evidence, economics, and ethics.
    Grosse SD; Rogowski WH; Ross LF; Cornel MC; Dondorp WJ; Khoury MJ
    Public Health Genomics; 2010; 13(2):106-15. PubMed ID: 19556749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial Mediterranean fever in northwest of Iran (Ardabil): the first global report from Iran.
    Salehzadeh F; Emami D; Zolfegari AA; Yazdanbod A; Habibzadeh S; Bashardost B; Barak M; Feizi I; Azimi H; Jastan M; Khalafi J
    Turk J Pediatr; 2008; 50(1):40-4. PubMed ID: 18365590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and new treatment modalities for familial Mediterranean fever.
    Bhat A; Naguwa SM; Gershwin ME
    Ann N Y Acad Sci; 2007 Sep; 1110():201-8. PubMed ID: 17911435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of Mendelian disorders to common chronic disease: opportunities for recognition, intervention, and prevention.
    Scheuner MT; Yoon PW; Khoury MJ
    Am J Med Genet C Semin Med Genet; 2004 Feb; 125C(1):50-65. PubMed ID: 14755434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance.
    Homsma SJ; Huijgen R; Middeldorp S; Sijbrands EJ; Kastelein JJ
    Eur J Hum Genet; 2008 Jan; 16(1):14-7. PubMed ID: 17957228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced method for the identification of patients with inherited hypercholesterolemia.
    Defesche JC; Lansberg PJ; Umans-Eckenhausen MA; Kastelein JJ
    Semin Vasc Med; 2004 Feb; 4(1):59-65. PubMed ID: 15199434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
    Bourbon M; Rato Q;
    Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for familial hypercholesterolemia: what is the most effective strategy?
    Daniels SR
    Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):130-1. PubMed ID: 18059381
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platform.
    Alonso R; Defesche JC; Tejedor D; Castillo S; Stef M; Mata N; Gomez-Enterria P; Martinez-Faedo C; Forga L; Mata P
    Clin Biochem; 2009 Jun; 42(9):899-903. PubMed ID: 19318025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic screening of patients with familial hypercholesterolemia and insurability for life insurance policies and disability cover policies].
    Homsma SJ; Lansberg PJ; Kastelein JJ
    Ned Tijdschr Geneeskd; 2004 Mar; 148(10):493-6. PubMed ID: 15042898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of plasminogen activator inhibitor-1 -675 4G/5G polymorphism on familial Mediterranean fever (FMF) disease.
    Ozel Demiralp D; Ekim M; Akar N
    Clin Appl Thromb Hemost; 2009; 15(4):443-7. PubMed ID: 19033264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of vascular endothelial growth factor gene 936 C/T polymorphism in patients with familial Mediterranean fever.
    Gunesacar R; Erken E; Ozer HT; Bozkurt B; Dinkci S; Deveci D
    Int J Immunogenet; 2008 Feb; 35(1):33-6. PubMed ID: 18186798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arg753Gln TLR-2 polymorphism in familial mediterranean fever: linking the environment to the phenotype in a monogenic inflammatory disease.
    Ozen S; Berdeli A; Türel B; Kutlay S; Yalcinkaya F; Arici M; Besbas N; Bakkaloglu A; Yilmaz E
    J Rheumatol; 2006 Dec; 33(12):2498-500. PubMed ID: 17013994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.